In Alzheimer’s disease (AD), decreased brain insulin levels are associated with elevated biomarkers such as amyloid β (Aβ) plaques, but also with neuro-psychiatric symptoms such as mood disorders and cognitive impairment, suggesting a possible connection between insulin resistance and neurodegeneration (Rhea et al. 2024). The gene discussed is INS; the disease is early-onset autosomal dominant Alzheimer disease.